Lincare Holdings Inc. provides oxygen, respiratory, and other chronic therapy services to patients in the home. Its principal products and services include home oxygen equipment, such as oxygen concentrators, which are stationary units that provide a continuous flow of oxygen by filtering ordinary room air; and liquid oxygen systems that are thermally insulated containers of liquid oxygen. The company also offers respiratory and chronic therapy services, including nebulizers and associated respiratory medications that provide aerosol therapy for customers suffering from chronic obstructive pulmonary disease (COPD) and asthma; continuous positive airway pressure devices, which maintain open airways in customers suffering from obstructive sleep apnea by providing airflow at prescribed pressures during sleep; non-invasive ventilation that offers nocturnal ventilatory support for customers with neuromuscular disease and COPD; and ventilators, which support respiratory function in severe cases of respiratory failure. In addition, its respiratory and chronic therapy services also include specialty pharmaceuticals; home anti-coagulation monitoring services that facilitate individuals on anti-coagulant therapy benefit; and pulmonary rehabilitation, a multi-dimensional outpatient program for the clinical management and health maintenance of patients with chronic respiratory diseases. Further, the company provides various home infusion therapies comprising parenteral nutrition, intravenous antibiotic therapy, enteral nutrition, chemotherapy, dobutamine infusions, immunoglobulin therapy, continuous pain management, and central catheter management. Additionally, it supplies home medical equipment, such as hospital beds, wheelchairs, and other supplies. The company serves customers in the home health care market through approximately 1,108 operating centers in the United States and Canada. Lincare Holdings Inc. was founded in 1972 and is headquartered in Clearwater, Florida.

Key Statistics